nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—ADRA2C—Brimonidine—glaucoma	0.0429	0.059	CbGbCtD
Doxepin—ADRA2C—Apraclonidine—glaucoma	0.0429	0.059	CbGbCtD
Doxepin—ADRA2B—Brimonidine—glaucoma	0.0407	0.056	CbGbCtD
Doxepin—ADRA2B—Apraclonidine—glaucoma	0.0407	0.056	CbGbCtD
Doxepin—ADRA2C—Dipivefrin—glaucoma	0.0343	0.0472	CbGbCtD
Doxepin—ADRA2B—Dipivefrin—glaucoma	0.0325	0.0448	CbGbCtD
Doxepin—CHRM3—Carbachol—glaucoma	0.0294	0.0405	CbGbCtD
Doxepin—ADRA2A—Brimonidine—glaucoma	0.0283	0.0389	CbGbCtD
Doxepin—ADRA2A—Apraclonidine—glaucoma	0.0283	0.0389	CbGbCtD
Doxepin—CHRM3—Pilocarpine—glaucoma	0.0274	0.0377	CbGbCtD
Doxepin—ADRA1A—Apraclonidine—glaucoma	0.0271	0.0373	CbGbCtD
Doxepin—CHRM1—Carbachol—glaucoma	0.0256	0.0352	CbGbCtD
Doxepin—CHRM1—Pilocarpine—glaucoma	0.0238	0.0328	CbGbCtD
Doxepin—CHRM2—Carbachol—glaucoma	0.0236	0.0325	CbGbCtD
Doxepin—ADRA2A—Dipivefrin—glaucoma	0.0226	0.0311	CbGbCtD
Doxepin—CHRM2—Pilocarpine—glaucoma	0.022	0.0302	CbGbCtD
Doxepin—ADRA1A—Dipivefrin—glaucoma	0.0217	0.0298	CbGbCtD
Doxepin—ADRA1D—Clonidine—glaucoma	0.0196	0.027	CbGbCtD
Doxepin—ADRA2C—Clonidine—glaucoma	0.0178	0.0245	CbGbCtD
Doxepin—ADRA2B—Clonidine—glaucoma	0.0169	0.0233	CbGbCtD
Doxepin—ADRA1B—Clonidine—glaucoma	0.0143	0.0196	CbGbCtD
Doxepin—SLC6A2—Clonidine—glaucoma	0.013	0.0179	CbGbCtD
Doxepin—ADRA2A—Clonidine—glaucoma	0.0118	0.0162	CbGbCtD
Doxepin—ADRA1A—Clonidine—glaucoma	0.0113	0.0155	CbGbCtD
Doxepin—CYP2D6—Carteolol—glaucoma	0.0106	0.0145	CbGbCtD
Doxepin—CYP1A2—Betaxolol—glaucoma	0.00866	0.0119	CbGbCtD
Doxepin—CYP2D6—Betaxolol—glaucoma	0.00713	0.00982	CbGbCtD
Doxepin—CYP2C19—Methazolamide—glaucoma	0.00711	0.00978	CbGbCtD
Doxepin—CYP2C9—Diclofenamide—glaucoma	0.00687	0.00945	CbGbCtD
Doxepin—CYP2C9—Dorzolamide—glaucoma	0.00663	0.00913	CbGbCtD
Doxepin—CYP2C19—Timolol—glaucoma	0.00605	0.00832	CbGbCtD
Doxepin—CYP2C9—Methazolamide—glaucoma	0.00591	0.00813	CbGbCtD
Doxepin—CYP2D6—Methazolamide—glaucoma	0.00541	0.00744	CbGbCtD
Doxepin—CYP3A4—Pilocarpine—glaucoma	0.00509	0.007	CbGbCtD
Doxepin—ABCB1—Timolol—glaucoma	0.00488	0.00671	CbGbCtD
Doxepin—CYP1A2—Clonidine—glaucoma	0.00474	0.00653	CbGbCtD
Doxepin—CYP2D6—Timolol—glaucoma	0.0046	0.00632	CbGbCtD
Doxepin—ABCB1—Clonidine—glaucoma	0.00415	0.00571	CbGbCtD
Doxepin—CYP3A4—Brinzolamide—glaucoma	0.00399	0.00549	CbGbCtD
Doxepin—CYP2D6—Clonidine—glaucoma	0.00391	0.00538	CbGbCtD
Doxepin—CYP3A4—Dorzolamide—glaucoma	0.00386	0.00531	CbGbCtD
Doxepin—CYP3A4—Methazolamide—glaucoma	0.00344	0.00473	CbGbCtD
Doxepin—CYP3A4—Acetazolamide—glaucoma	0.00275	0.00378	CbGbCtD
Doxepin—CYP3A4—Clonidine—glaucoma	0.00249	0.00342	CbGbCtD
Doxepin—Amitriptyline—NTRK2—glaucoma	0.000508	0.618	CrCbGaD
Doxepin—Amitriptyline—NTRK1—glaucoma	0.000314	0.382	CrCbGaD
Doxepin—Alopecia—Betaxolol—glaucoma	9.03e-05	0.000423	CcSEcCtD
Doxepin—Palpitations—Clonidine—glaucoma	9.03e-05	0.000423	CcSEcCtD
Doxepin—Gastrointestinal disorder—Pilocarpine—glaucoma	9.01e-05	0.000422	CcSEcCtD
Doxepin—Gastrointestinal pain—Travoprost—glaucoma	9e-05	0.000421	CcSEcCtD
Doxepin—Loss of consciousness—Clonidine—glaucoma	8.98e-05	0.00042	CcSEcCtD
Doxepin—Feeling abnormal—Brinzolamide—glaucoma	8.95e-05	0.000419	CcSEcCtD
Doxepin—Mental disorder—Betaxolol—glaucoma	8.95e-05	0.000419	CcSEcCtD
Doxepin—Constipation—Pilocarpine—glaucoma	8.93e-05	0.000418	CcSEcCtD
Doxepin—Pain—Pilocarpine—glaucoma	8.93e-05	0.000418	CcSEcCtD
Doxepin—Cough—Clonidine—glaucoma	8.91e-05	0.000417	CcSEcCtD
Doxepin—Sweating—Timolol—glaucoma	8.91e-05	0.000417	CcSEcCtD
Doxepin—Dizziness—Apraclonidine—glaucoma	8.91e-05	0.000417	CcSEcCtD
Doxepin—Erythema—Betaxolol—glaucoma	8.89e-05	0.000416	CcSEcCtD
Doxepin—Malnutrition—Betaxolol—glaucoma	8.89e-05	0.000416	CcSEcCtD
Doxepin—Urticaria—Dorzolamide—glaucoma	8.78e-05	0.000411	CcSEcCtD
Doxepin—Body temperature increased—Dorzolamide—glaucoma	8.73e-05	0.000409	CcSEcCtD
Doxepin—Abdominal pain—Dorzolamide—glaucoma	8.73e-05	0.000409	CcSEcCtD
Doxepin—Tension—Betaxolol—glaucoma	8.73e-05	0.000408	CcSEcCtD
Doxepin—Sinusitis—Timolol—glaucoma	8.72e-05	0.000408	CcSEcCtD
Doxepin—Dysgeusia—Betaxolol—glaucoma	8.71e-05	0.000408	CcSEcCtD
Doxepin—Arthralgia—Clonidine—glaucoma	8.7e-05	0.000407	CcSEcCtD
Doxepin—Chest pain—Clonidine—glaucoma	8.7e-05	0.000407	CcSEcCtD
Doxepin—Abdominal pain—Travoprost—glaucoma	8.7e-05	0.000407	CcSEcCtD
Doxepin—Agranulocytosis—Timolol—glaucoma	8.68e-05	0.000406	CcSEcCtD
Doxepin—Anxiety—Clonidine—glaucoma	8.67e-05	0.000406	CcSEcCtD
Doxepin—Asthenia—Acetazolamide—glaucoma	8.65e-05	0.000405	CcSEcCtD
Doxepin—Dizziness—Bimatoprost—glaucoma	8.64e-05	0.000404	CcSEcCtD
Doxepin—Nervousness—Betaxolol—glaucoma	8.64e-05	0.000404	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	8.64e-05	0.000404	CcSEcCtD
Doxepin—Urticaria—Brinzolamide—glaucoma	8.63e-05	0.000404	CcSEcCtD
Doxepin—Feeling abnormal—Pilocarpine—glaucoma	8.6e-05	0.000403	CcSEcCtD
Doxepin—Discomfort—Clonidine—glaucoma	8.59e-05	0.000402	CcSEcCtD
Doxepin—Vomiting—Apraclonidine—glaucoma	8.57e-05	0.000401	CcSEcCtD
Doxepin—Muscle spasms—Betaxolol—glaucoma	8.55e-05	0.0004	CcSEcCtD
Doxepin—Gastrointestinal pain—Pilocarpine—glaucoma	8.54e-05	0.0004	CcSEcCtD
Doxepin—Hypersensitivity—Brimonidine—glaucoma	8.52e-05	0.000399	CcSEcCtD
Doxepin—Dry mouth—Clonidine—glaucoma	8.51e-05	0.000398	CcSEcCtD
Doxepin—Bradycardia—Timolol—glaucoma	8.5e-05	0.000398	CcSEcCtD
Doxepin—Dermatitis—Apraclonidine—glaucoma	8.49e-05	0.000397	CcSEcCtD
Doxepin—Headache—Apraclonidine—glaucoma	8.44e-05	0.000395	CcSEcCtD
Doxepin—Confusional state—Clonidine—glaucoma	8.41e-05	0.000393	CcSEcCtD
Doxepin—Vision blurred—Betaxolol—glaucoma	8.38e-05	0.000392	CcSEcCtD
Doxepin—Oedema—Clonidine—glaucoma	8.34e-05	0.00039	CcSEcCtD
Doxepin—Tremor—Betaxolol—glaucoma	8.33e-05	0.00039	CcSEcCtD
Doxepin—Hallucination—Timolol—glaucoma	8.3e-05	0.000389	CcSEcCtD
Doxepin—Asthenia—Brimonidine—glaucoma	8.3e-05	0.000388	CcSEcCtD
Doxepin—Infection—Clonidine—glaucoma	8.28e-05	0.000388	CcSEcCtD
Doxepin—Abdominal pain—Pilocarpine—glaucoma	8.25e-05	0.000386	CcSEcCtD
Doxepin—Body temperature increased—Pilocarpine—glaucoma	8.25e-05	0.000386	CcSEcCtD
Doxepin—Ill-defined disorder—Betaxolol—glaucoma	8.25e-05	0.000386	CcSEcCtD
Doxepin—Diarrhoea—Acetazolamide—glaucoma	8.25e-05	0.000386	CcSEcCtD
Doxepin—Rash—Bimatoprost—glaucoma	8.24e-05	0.000386	CcSEcCtD
Doxepin—Dermatitis—Bimatoprost—glaucoma	8.23e-05	0.000385	CcSEcCtD
Doxepin—Oedema peripheral—Timolol—glaucoma	8.22e-05	0.000385	CcSEcCtD
Doxepin—Anaemia—Betaxolol—glaucoma	8.22e-05	0.000385	CcSEcCtD
Doxepin—Shock—Clonidine—glaucoma	8.2e-05	0.000384	CcSEcCtD
Doxepin—Connective tissue disorder—Timolol—glaucoma	8.2e-05	0.000384	CcSEcCtD
Doxepin—Pruritus—Brimonidine—glaucoma	8.19e-05	0.000383	CcSEcCtD
Doxepin—Headache—Bimatoprost—glaucoma	8.19e-05	0.000383	CcSEcCtD
Doxepin—Nervous system disorder—Clonidine—glaucoma	8.18e-05	0.000383	CcSEcCtD
Doxepin—Thrombocytopenia—Clonidine—glaucoma	8.16e-05	0.000382	CcSEcCtD
Doxepin—Hypersensitivity—Dorzolamide—glaucoma	8.14e-05	0.000381	CcSEcCtD
Doxepin—Tachycardia—Clonidine—glaucoma	8.14e-05	0.000381	CcSEcCtD
Doxepin—Hypersensitivity—Travoprost—glaucoma	8.11e-05	0.000379	CcSEcCtD
Doxepin—Skin disorder—Clonidine—glaucoma	8.1e-05	0.000379	CcSEcCtD
Doxepin—Hyperhidrosis—Clonidine—glaucoma	8.06e-05	0.000377	CcSEcCtD
Doxepin—Malaise—Betaxolol—glaucoma	8.02e-05	0.000375	CcSEcCtD
Doxepin—Nausea—Apraclonidine—glaucoma	8e-05	0.000375	CcSEcCtD
Doxepin—Hypersensitivity—Brinzolamide—glaucoma	8e-05	0.000375	CcSEcCtD
Doxepin—Vertigo—Betaxolol—glaucoma	7.99e-05	0.000374	CcSEcCtD
Doxepin—Syncope—Betaxolol—glaucoma	7.98e-05	0.000373	CcSEcCtD
Doxepin—Dizziness—Acetazolamide—glaucoma	7.97e-05	0.000373	CcSEcCtD
Doxepin—Anorexia—Clonidine—glaucoma	7.95e-05	0.000372	CcSEcCtD
Doxepin—Asthenia—Dorzolamide—glaucoma	7.93e-05	0.000371	CcSEcCtD
Doxepin—Asthenia—Travoprost—glaucoma	7.89e-05	0.000369	CcSEcCtD
Doxepin—Palpitations—Betaxolol—glaucoma	7.86e-05	0.000368	CcSEcCtD
Doxepin—Pruritus—Dorzolamide—glaucoma	7.82e-05	0.000366	CcSEcCtD
Doxepin—Loss of consciousness—Betaxolol—glaucoma	7.82e-05	0.000366	CcSEcCtD
Doxepin—Eye disorder—Timolol—glaucoma	7.8e-05	0.000365	CcSEcCtD
Doxepin—Asthenia—Brinzolamide—glaucoma	7.79e-05	0.000365	CcSEcCtD
Doxepin—Hypotension—Clonidine—glaucoma	7.79e-05	0.000365	CcSEcCtD
Doxepin—Pruritus—Travoprost—glaucoma	7.78e-05	0.000364	CcSEcCtD
Doxepin—Tinnitus—Timolol—glaucoma	7.78e-05	0.000364	CcSEcCtD
Doxepin—Cough—Betaxolol—glaucoma	7.76e-05	0.000363	CcSEcCtD
Doxepin—Nausea—Bimatoprost—glaucoma	7.76e-05	0.000363	CcSEcCtD
Doxepin—Cardiac disorder—Timolol—glaucoma	7.75e-05	0.000363	CcSEcCtD
Doxepin—Hypersensitivity—Pilocarpine—glaucoma	7.69e-05	0.00036	CcSEcCtD
Doxepin—Pruritus—Brinzolamide—glaucoma	7.69e-05	0.00036	CcSEcCtD
Doxepin—Vomiting—Acetazolamide—glaucoma	7.66e-05	0.000359	CcSEcCtD
Doxepin—Dizziness—Brimonidine—glaucoma	7.65e-05	0.000358	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Clonidine—glaucoma	7.6e-05	0.000355	CcSEcCtD
Doxepin—Angiopathy—Timolol—glaucoma	7.57e-05	0.000354	CcSEcCtD
Doxepin—Chest pain—Betaxolol—glaucoma	7.57e-05	0.000354	CcSEcCtD
Doxepin—Myalgia—Betaxolol—glaucoma	7.57e-05	0.000354	CcSEcCtD
Doxepin—Arthralgia—Betaxolol—glaucoma	7.57e-05	0.000354	CcSEcCtD
Doxepin—Diarrhoea—Dorzolamide—glaucoma	7.56e-05	0.000354	CcSEcCtD
Doxepin—Headache—Acetazolamide—glaucoma	7.55e-05	0.000353	CcSEcCtD
Doxepin—Anxiety—Betaxolol—glaucoma	7.55e-05	0.000353	CcSEcCtD
Doxepin—Insomnia—Clonidine—glaucoma	7.54e-05	0.000353	CcSEcCtD
Doxepin—Immune system disorder—Timolol—glaucoma	7.54e-05	0.000353	CcSEcCtD
Doxepin—Diarrhoea—Travoprost—glaucoma	7.53e-05	0.000352	CcSEcCtD
Doxepin—Mediastinal disorder—Timolol—glaucoma	7.52e-05	0.000352	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	7.52e-05	0.000352	CcSEcCtD
Doxepin—Asthenia—Pilocarpine—glaucoma	7.49e-05	0.000351	CcSEcCtD
Doxepin—Paraesthesia—Clonidine—glaucoma	7.49e-05	0.00035	CcSEcCtD
Doxepin—Discomfort—Betaxolol—glaucoma	7.48e-05	0.00035	CcSEcCtD
Doxepin—Arrhythmia—Timolol—glaucoma	7.46e-05	0.000349	CcSEcCtD
Doxepin—Dyspnoea—Clonidine—glaucoma	7.43e-05	0.000348	CcSEcCtD
Doxepin—Diarrhoea—Brinzolamide—glaucoma	7.43e-05	0.000348	CcSEcCtD
Doxepin—Somnolence—Clonidine—glaucoma	7.41e-05	0.000347	CcSEcCtD
Doxepin—Dry mouth—Betaxolol—glaucoma	7.41e-05	0.000347	CcSEcCtD
Doxepin—Pruritus—Pilocarpine—glaucoma	7.39e-05	0.000346	CcSEcCtD
Doxepin—Alopecia—Timolol—glaucoma	7.38e-05	0.000345	CcSEcCtD
Doxepin—Confusional state—Betaxolol—glaucoma	7.32e-05	0.000343	CcSEcCtD
Doxepin—Mental disorder—Timolol—glaucoma	7.31e-05	0.000342	CcSEcCtD
Doxepin—Dizziness—Dorzolamide—glaucoma	7.31e-05	0.000342	CcSEcCtD
Doxepin—Rash—Brimonidine—glaucoma	7.29e-05	0.000341	CcSEcCtD
Doxepin—Dermatitis—Brimonidine—glaucoma	7.29e-05	0.000341	CcSEcCtD
Doxepin—Dizziness—Travoprost—glaucoma	7.28e-05	0.00034	CcSEcCtD
Doxepin—Erythema—Timolol—glaucoma	7.27e-05	0.00034	CcSEcCtD
Doxepin—Malnutrition—Timolol—glaucoma	7.27e-05	0.00034	CcSEcCtD
Doxepin—Oedema—Betaxolol—glaucoma	7.26e-05	0.00034	CcSEcCtD
Doxepin—Headache—Brimonidine—glaucoma	7.25e-05	0.000339	CcSEcCtD
Doxepin—Decreased appetite—Clonidine—glaucoma	7.25e-05	0.000339	CcSEcCtD
Doxepin—Infection—Betaxolol—glaucoma	7.21e-05	0.000337	CcSEcCtD
Doxepin—Gastrointestinal disorder—Clonidine—glaucoma	7.2e-05	0.000337	CcSEcCtD
Doxepin—Fatigue—Clonidine—glaucoma	7.19e-05	0.000336	CcSEcCtD
Doxepin—Dizziness—Brinzolamide—glaucoma	7.18e-05	0.000336	CcSEcCtD
Doxepin—Nausea—Acetazolamide—glaucoma	7.16e-05	0.000335	CcSEcCtD
Doxepin—Diarrhoea—Pilocarpine—glaucoma	7.14e-05	0.000334	CcSEcCtD
Doxepin—Shock—Betaxolol—glaucoma	7.14e-05	0.000334	CcSEcCtD
Doxepin—Tension—Timolol—glaucoma	7.13e-05	0.000334	CcSEcCtD
Doxepin—Constipation—Clonidine—glaucoma	7.13e-05	0.000334	CcSEcCtD
Doxepin—Pain—Clonidine—glaucoma	7.13e-05	0.000334	CcSEcCtD
Doxepin—Nervous system disorder—Betaxolol—glaucoma	7.12e-05	0.000333	CcSEcCtD
Doxepin—Dysgeusia—Timolol—glaucoma	7.12e-05	0.000333	CcSEcCtD
Doxepin—Thrombocytopenia—Betaxolol—glaucoma	7.11e-05	0.000333	CcSEcCtD
Doxepin—Tachycardia—Betaxolol—glaucoma	7.08e-05	0.000332	CcSEcCtD
Doxepin—Nervousness—Timolol—glaucoma	7.06e-05	0.00033	CcSEcCtD
Doxepin—Skin disorder—Betaxolol—glaucoma	7.05e-05	0.00033	CcSEcCtD
Doxepin—Vomiting—Dorzolamide—glaucoma	7.03e-05	0.000329	CcSEcCtD
Doxepin—Hyperhidrosis—Betaxolol—glaucoma	7.02e-05	0.000328	CcSEcCtD
Doxepin—Rash—Dorzolamide—glaucoma	6.97e-05	0.000326	CcSEcCtD
Doxepin—Dermatitis—Dorzolamide—glaucoma	6.96e-05	0.000326	CcSEcCtD
Doxepin—Rash—Travoprost—glaucoma	6.94e-05	0.000325	CcSEcCtD
Doxepin—Dermatitis—Travoprost—glaucoma	6.93e-05	0.000324	CcSEcCtD
Doxepin—Headache—Dorzolamide—glaucoma	6.92e-05	0.000324	CcSEcCtD
Doxepin—Anorexia—Betaxolol—glaucoma	6.92e-05	0.000324	CcSEcCtD
Doxepin—Vomiting—Brinzolamide—glaucoma	6.91e-05	0.000323	CcSEcCtD
Doxepin—Dizziness—Pilocarpine—glaucoma	6.9e-05	0.000323	CcSEcCtD
Doxepin—Headache—Travoprost—glaucoma	6.89e-05	0.000323	CcSEcCtD
Doxepin—Nausea—Brimonidine—glaucoma	6.87e-05	0.000322	CcSEcCtD
Doxepin—Feeling abnormal—Clonidine—glaucoma	6.87e-05	0.000322	CcSEcCtD
Doxepin—Rash—Brinzolamide—glaucoma	6.85e-05	0.000321	CcSEcCtD
Doxepin—Vision blurred—Timolol—glaucoma	6.85e-05	0.00032	CcSEcCtD
Doxepin—Dermatitis—Brinzolamide—glaucoma	6.84e-05	0.00032	CcSEcCtD
Doxepin—Gastrointestinal pain—Clonidine—glaucoma	6.82e-05	0.000319	CcSEcCtD
Doxepin—Headache—Brinzolamide—glaucoma	6.81e-05	0.000318	CcSEcCtD
Doxepin—Hypotension—Betaxolol—glaucoma	6.78e-05	0.000317	CcSEcCtD
Doxepin—Vomiting—Pilocarpine—glaucoma	6.64e-05	0.000311	CcSEcCtD
Doxepin—Urticaria—Clonidine—glaucoma	6.62e-05	0.00031	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Betaxolol—glaucoma	6.61e-05	0.000309	CcSEcCtD
Doxepin—Abdominal pain—Clonidine—glaucoma	6.59e-05	0.000308	CcSEcCtD
Doxepin—Body temperature increased—Clonidine—glaucoma	6.59e-05	0.000308	CcSEcCtD
Doxepin—Rash—Pilocarpine—glaucoma	6.58e-05	0.000308	CcSEcCtD
Doxepin—Dermatitis—Pilocarpine—glaucoma	6.58e-05	0.000308	CcSEcCtD
Doxepin—Insomnia—Betaxolol—glaucoma	6.57e-05	0.000307	CcSEcCtD
Doxepin—Nausea—Dorzolamide—glaucoma	6.56e-05	0.000307	CcSEcCtD
Doxepin—Headache—Pilocarpine—glaucoma	6.54e-05	0.000306	CcSEcCtD
Doxepin—Nausea—Travoprost—glaucoma	6.53e-05	0.000306	CcSEcCtD
Doxepin—Vertigo—Timolol—glaucoma	6.53e-05	0.000306	CcSEcCtD
Doxepin—Paraesthesia—Betaxolol—glaucoma	6.52e-05	0.000305	CcSEcCtD
Doxepin—Syncope—Timolol—glaucoma	6.52e-05	0.000305	CcSEcCtD
Doxepin—Dyspnoea—Betaxolol—glaucoma	6.47e-05	0.000303	CcSEcCtD
Doxepin—Nausea—Brinzolamide—glaucoma	6.45e-05	0.000302	CcSEcCtD
Doxepin—Palpitations—Timolol—glaucoma	6.42e-05	0.0003	CcSEcCtD
Doxepin—Dyspepsia—Betaxolol—glaucoma	6.39e-05	0.000299	CcSEcCtD
Doxepin—Loss of consciousness—Timolol—glaucoma	6.39e-05	0.000299	CcSEcCtD
Doxepin—Cough—Timolol—glaucoma	6.34e-05	0.000297	CcSEcCtD
Doxepin—Decreased appetite—Betaxolol—glaucoma	6.31e-05	0.000295	CcSEcCtD
Doxepin—Hypertension—Timolol—glaucoma	6.27e-05	0.000294	CcSEcCtD
Doxepin—Gastrointestinal disorder—Betaxolol—glaucoma	6.27e-05	0.000293	CcSEcCtD
Doxepin—Fatigue—Betaxolol—glaucoma	6.26e-05	0.000293	CcSEcCtD
Doxepin—Constipation—Betaxolol—glaucoma	6.21e-05	0.00029	CcSEcCtD
Doxepin—Pain—Betaxolol—glaucoma	6.21e-05	0.00029	CcSEcCtD
Doxepin—Nausea—Pilocarpine—glaucoma	6.2e-05	0.00029	CcSEcCtD
Doxepin—Arthralgia—Timolol—glaucoma	6.19e-05	0.000289	CcSEcCtD
Doxepin—Myalgia—Timolol—glaucoma	6.19e-05	0.000289	CcSEcCtD
Doxepin—Chest pain—Timolol—glaucoma	6.19e-05	0.000289	CcSEcCtD
Doxepin—Anxiety—Timolol—glaucoma	6.16e-05	0.000288	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	6.14e-05	0.000288	CcSEcCtD
Doxepin—Hypersensitivity—Clonidine—glaucoma	6.14e-05	0.000287	CcSEcCtD
Doxepin—Discomfort—Timolol—glaucoma	6.11e-05	0.000286	CcSEcCtD
Doxepin—Dry mouth—Timolol—glaucoma	6.05e-05	0.000283	CcSEcCtD
Doxepin—Asthenia—Clonidine—glaucoma	5.98e-05	0.00028	CcSEcCtD
Doxepin—Feeling abnormal—Betaxolol—glaucoma	5.98e-05	0.00028	CcSEcCtD
Doxepin—Confusional state—Timolol—glaucoma	5.98e-05	0.00028	CcSEcCtD
Doxepin—Oedema—Timolol—glaucoma	5.93e-05	0.000278	CcSEcCtD
Doxepin—Pruritus—Clonidine—glaucoma	5.9e-05	0.000276	CcSEcCtD
Doxepin—Infection—Timolol—glaucoma	5.89e-05	0.000276	CcSEcCtD
Doxepin—Shock—Timolol—glaucoma	5.83e-05	0.000273	CcSEcCtD
Doxepin—Nervous system disorder—Timolol—glaucoma	5.82e-05	0.000272	CcSEcCtD
Doxepin—Urticaria—Betaxolol—glaucoma	5.77e-05	0.00027	CcSEcCtD
Doxepin—Skin disorder—Timolol—glaucoma	5.76e-05	0.00027	CcSEcCtD
Doxepin—Body temperature increased—Betaxolol—glaucoma	5.74e-05	0.000269	CcSEcCtD
Doxepin—Hyperhidrosis—Timolol—glaucoma	5.73e-05	0.000268	CcSEcCtD
Doxepin—Diarrhoea—Clonidine—glaucoma	5.7e-05	0.000267	CcSEcCtD
Doxepin—Anorexia—Timolol—glaucoma	5.65e-05	0.000265	CcSEcCtD
Doxepin—Hypotension—Timolol—glaucoma	5.54e-05	0.000259	CcSEcCtD
Doxepin—Dizziness—Clonidine—glaucoma	5.51e-05	0.000258	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Timolol—glaucoma	5.4e-05	0.000253	CcSEcCtD
Doxepin—Insomnia—Timolol—glaucoma	5.36e-05	0.000251	CcSEcCtD
Doxepin—Hypersensitivity—Betaxolol—glaucoma	5.35e-05	0.00025	CcSEcCtD
Doxepin—Paraesthesia—Timolol—glaucoma	5.32e-05	0.000249	CcSEcCtD
Doxepin—Vomiting—Clonidine—glaucoma	5.3e-05	0.000248	CcSEcCtD
Doxepin—Dyspnoea—Timolol—glaucoma	5.29e-05	0.000247	CcSEcCtD
Doxepin—Somnolence—Timolol—glaucoma	5.27e-05	0.000247	CcSEcCtD
Doxepin—Rash—Clonidine—glaucoma	5.26e-05	0.000246	CcSEcCtD
Doxepin—Dermatitis—Clonidine—glaucoma	5.25e-05	0.000246	CcSEcCtD
Doxepin—Headache—Clonidine—glaucoma	5.22e-05	0.000244	CcSEcCtD
Doxepin—Dyspepsia—Timolol—glaucoma	5.22e-05	0.000244	CcSEcCtD
Doxepin—Asthenia—Betaxolol—glaucoma	5.21e-05	0.000244	CcSEcCtD
Doxepin—Decreased appetite—Timolol—glaucoma	5.15e-05	0.000241	CcSEcCtD
Doxepin—Pruritus—Betaxolol—glaucoma	5.14e-05	0.00024	CcSEcCtD
Doxepin—Gastrointestinal disorder—Timolol—glaucoma	5.12e-05	0.00024	CcSEcCtD
Doxepin—Fatigue—Timolol—glaucoma	5.11e-05	0.000239	CcSEcCtD
Doxepin—Pain—Timolol—glaucoma	5.07e-05	0.000237	CcSEcCtD
Doxepin—Diarrhoea—Betaxolol—glaucoma	4.97e-05	0.000232	CcSEcCtD
Doxepin—Nausea—Clonidine—glaucoma	4.95e-05	0.000232	CcSEcCtD
Doxepin—Feeling abnormal—Timolol—glaucoma	4.89e-05	0.000229	CcSEcCtD
Doxepin—Gastrointestinal pain—Timolol—glaucoma	4.85e-05	0.000227	CcSEcCtD
Doxepin—Dizziness—Betaxolol—glaucoma	4.8e-05	0.000225	CcSEcCtD
Doxepin—Urticaria—Timolol—glaucoma	4.71e-05	0.00022	CcSEcCtD
Doxepin—Abdominal pain—Timolol—glaucoma	4.69e-05	0.000219	CcSEcCtD
Doxepin—Body temperature increased—Timolol—glaucoma	4.69e-05	0.000219	CcSEcCtD
Doxepin—Vomiting—Betaxolol—glaucoma	4.62e-05	0.000216	CcSEcCtD
Doxepin—Rash—Betaxolol—glaucoma	4.58e-05	0.000214	CcSEcCtD
Doxepin—Dermatitis—Betaxolol—glaucoma	4.57e-05	0.000214	CcSEcCtD
Doxepin—Headache—Betaxolol—glaucoma	4.55e-05	0.000213	CcSEcCtD
Doxepin—Hypersensitivity—Timolol—glaucoma	4.37e-05	0.000204	CcSEcCtD
Doxepin—Nausea—Betaxolol—glaucoma	4.31e-05	0.000202	CcSEcCtD
Doxepin—Asthenia—Timolol—glaucoma	4.25e-05	0.000199	CcSEcCtD
Doxepin—Pruritus—Timolol—glaucoma	4.2e-05	0.000196	CcSEcCtD
Doxepin—Diarrhoea—Timolol—glaucoma	4.06e-05	0.00019	CcSEcCtD
Doxepin—Dizziness—Timolol—glaucoma	3.92e-05	0.000184	CcSEcCtD
Doxepin—Vomiting—Timolol—glaucoma	3.77e-05	0.000176	CcSEcCtD
Doxepin—Rash—Timolol—glaucoma	3.74e-05	0.000175	CcSEcCtD
Doxepin—Dermatitis—Timolol—glaucoma	3.74e-05	0.000175	CcSEcCtD
Doxepin—Headache—Timolol—glaucoma	3.71e-05	0.000174	CcSEcCtD
Doxepin—Nausea—Timolol—glaucoma	3.52e-05	0.000165	CcSEcCtD
Doxepin—CHRM3—Metabolism—MTHFR—glaucoma	5.73e-06	9.74e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CDKN2B—glaucoma	5.71e-06	9.71e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NGF—glaucoma	5.69e-06	9.68e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NTRK1—glaucoma	5.69e-06	9.67e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CDKN2B—glaucoma	5.66e-06	9.62e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	5.64e-06	9.59e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—FN1—glaucoma	5.63e-06	9.58e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EDN1—glaucoma	5.62e-06	9.55e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NGF—glaucoma	5.6e-06	9.52e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—C3—glaucoma	5.59e-06	9.51e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—BAD—glaucoma	5.57e-06	9.46e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—C3—glaucoma	5.56e-06	9.46e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EDN1—glaucoma	5.53e-06	9.4e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EDN1—glaucoma	5.52e-06	9.38e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MMP9—glaucoma	5.51e-06	9.37e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EDN1—glaucoma	5.5e-06	9.35e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EDN1—glaucoma	5.48e-06	9.32e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EDN1—glaucoma	5.43e-06	9.23e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EDN1—glaucoma	5.41e-06	9.21e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—C3—glaucoma	5.41e-06	9.2e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—APOE—glaucoma	5.39e-06	9.17e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CAV1—glaucoma	5.34e-06	9.08e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.33e-06	9.07e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—APOE—glaucoma	5.33e-06	9.07e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—C3—glaucoma	5.32e-06	9.05e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—CAV1—glaucoma	5.28e-06	8.98e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ABCA1—glaucoma	5.27e-06	8.96e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CYP1B1—glaucoma	5.27e-06	8.96e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—NOS3—glaucoma	5.27e-06	8.96e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—MTHFR—glaucoma	5.26e-06	8.94e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	5.24e-06	8.91e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—APOE—glaucoma	5.2e-06	8.85e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—APOE—glaucoma	5.18e-06	8.81e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NGF—glaucoma	5.16e-06	8.78e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CAV1—glaucoma	5.16e-06	8.77e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GSTT1—glaucoma	5.15e-06	8.76e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CYP1B1—glaucoma	5.14e-06	8.75e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ABCA1—glaucoma	5.14e-06	8.75e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CAV1—glaucoma	5.13e-06	8.72e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TXN—glaucoma	5.13e-06	8.72e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—FN1—glaucoma	5.08e-06	8.65e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NGF—glaucoma	5.08e-06	8.64e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NGF—glaucoma	5.07e-06	8.62e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NGF—glaucoma	5.05e-06	8.59e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NGF—glaucoma	5.04e-06	8.57e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—APOE—glaucoma	5.04e-06	8.56e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EDN1—glaucoma	5.03e-06	8.55e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—BAD—glaucoma	5.02e-06	8.54e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CAV1—glaucoma	4.99e-06	8.49e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NGF—glaucoma	4.99e-06	8.48e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NGF—glaucoma	4.97e-06	8.46e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—NOS3—glaucoma	4.97e-06	8.45e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—APOE—glaucoma	4.96e-06	8.43e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—VEGFA—glaucoma	4.95e-06	8.41e-05	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—TP53—glaucoma	4.92e-06	8.37e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CAV1—glaucoma	4.91e-06	8.35e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—C3—glaucoma	4.91e-06	8.35e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—FN1—glaucoma	4.91e-06	8.35e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—APOE—glaucoma	4.89e-06	8.32e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—FN1—glaucoma	4.88e-06	8.3e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.86e-06	8.27e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—BAD—glaucoma	4.85e-06	8.25e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CAV1—glaucoma	4.85e-06	8.24e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ABCA1—glaucoma	4.85e-06	8.24e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CYP1B1—glaucoma	4.85e-06	8.24e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—C3—glaucoma	4.83e-06	8.21e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—BAD—glaucoma	4.83e-06	8.21e-05	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—TP53—glaucoma	4.82e-06	8.2e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—C3—glaucoma	4.82e-06	8.2e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—NOS3—glaucoma	4.81e-06	8.18e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ABCA1—glaucoma	4.8e-06	8.17e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CYP1B1—glaucoma	4.8e-06	8.17e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—C3—glaucoma	4.8e-06	8.17e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—C3—glaucoma	4.79e-06	8.14e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—NOS3—glaucoma	4.76e-06	8.09e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—FN1—glaucoma	4.75e-06	8.08e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—C3—glaucoma	4.74e-06	8.06e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—C3—glaucoma	4.73e-06	8.04e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—BAD—glaucoma	4.69e-06	7.98e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—FN1—glaucoma	4.67e-06	7.95e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NGF—glaucoma	4.62e-06	7.86e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—BAD—glaucoma	4.62e-06	7.85e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—APOE—glaucoma	4.57e-06	7.77e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CDKN1B—glaucoma	4.56e-06	7.76e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CAV1—glaucoma	4.53e-06	7.7e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—NOS3—glaucoma	4.51e-06	7.67e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—APOE—glaucoma	4.5e-06	7.65e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—APOE—glaucoma	4.49e-06	7.63e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NOS3—glaucoma	4.47e-06	7.61e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—APOE—glaucoma	4.47e-06	7.61e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—APOE—glaucoma	4.46e-06	7.58e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CAV1—glaucoma	4.46e-06	7.58e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CAV1—glaucoma	4.45e-06	7.56e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CAV1—glaucoma	4.43e-06	7.54e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CAV1—glaucoma	4.42e-06	7.51e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—APOE—glaucoma	4.41e-06	7.51e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—APOE—glaucoma	4.4e-06	7.49e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—C3—glaucoma	4.39e-06	7.47e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CAV1—glaucoma	4.37e-06	7.44e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CAV1—glaucoma	4.36e-06	7.42e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—FN1—glaucoma	4.31e-06	7.33e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CDKN1B—glaucoma	4.3e-06	7.32e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—BAD—glaucoma	4.26e-06	7.24e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—FN1—glaucoma	4.24e-06	7.21e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—FN1—glaucoma	4.23e-06	7.2e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MMP9—glaucoma	4.23e-06	7.19e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—FN1—glaucoma	4.22e-06	7.17e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GSTM1—glaucoma	4.21e-06	7.16e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—FN1—glaucoma	4.2e-06	7.15e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—BAD—glaucoma	4.19e-06	7.13e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—BAD—glaucoma	4.18e-06	7.11e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—BAD—glaucoma	4.17e-06	7.09e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CDKN1B—glaucoma	4.17e-06	7.08e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—FN1—glaucoma	4.16e-06	7.08e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.16e-06	7.07e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—BAD—glaucoma	4.15e-06	7.06e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—FN1—glaucoma	4.15e-06	7.06e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PTGS2—glaucoma	4.13e-06	7.02e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CDKN1B—glaucoma	4.12e-06	7.01e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—BAD—glaucoma	4.11e-06	7e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GSTM1—glaucoma	4.11e-06	6.99e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ABCA1—glaucoma	4.11e-06	6.98e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CYP1B1—glaucoma	4.11e-06	6.98e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—BAD—glaucoma	4.1e-06	6.98e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—APOE—glaucoma	4.09e-06	6.96e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CAV1—glaucoma	4.05e-06	6.89e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NOS3—glaucoma	4.04e-06	6.87e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—NOS3—glaucoma	3.99e-06	6.79e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MMP9—glaucoma	3.99e-06	6.78e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTT1—glaucoma	3.98e-06	6.76e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NOS3—glaucoma	3.9e-06	6.63e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NOS3—glaucoma	3.88e-06	6.6e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	3.88e-06	6.59e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GSTM1—glaucoma	3.87e-06	6.59e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MMP9—glaucoma	3.86e-06	6.56e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—FN1—glaucoma	3.86e-06	6.56e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GSTM1—glaucoma	3.84e-06	6.53e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MMP9—glaucoma	3.82e-06	6.49e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—BAD—glaucoma	3.81e-06	6.48e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—VEGFA—glaucoma	3.8e-06	6.45e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NOS3—glaucoma	3.77e-06	6.42e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—glaucoma	3.74e-06	6.36e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—MTHFR—glaucoma	3.72e-06	6.33e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NOS3—glaucoma	3.71e-06	6.31e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—NOS3—glaucoma	3.67e-06	6.23e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTGS2—glaucoma	3.65e-06	6.21e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—MTHFR—glaucoma	3.63e-06	6.18e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MMP9—glaucoma	3.59e-06	6.1e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—VEGFA—glaucoma	3.58e-06	6.09e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	3.5e-06	5.95e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOE—glaucoma	3.47e-06	5.89e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—VEGFA—glaucoma	3.46e-06	5.89e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CAV1—glaucoma	3.43e-06	5.84e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—VEGFA—glaucoma	3.43e-06	5.83e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—MTHFR—glaucoma	3.42e-06	5.82e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NOS3—glaucoma	3.42e-06	5.82e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—MTHFR—glaucoma	3.39e-06	5.77e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOE—glaucoma	3.38e-06	5.75e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CDKN1B—glaucoma	3.38e-06	5.74e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NOS3—glaucoma	3.37e-06	5.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NOS3—glaucoma	3.36e-06	5.72e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CDKN1B—glaucoma	3.36e-06	5.71e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTGS2—glaucoma	3.35e-06	5.7e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CAV1—glaucoma	3.35e-06	5.7e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NOS3—glaucoma	3.35e-06	5.7e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NOS3—glaucoma	3.34e-06	5.68e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NOS3—glaucoma	3.31e-06	5.62e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NOS3—glaucoma	3.3e-06	5.61e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GSTM1—glaucoma	3.28e-06	5.58e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	3.27e-06	5.56e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MMP9—glaucoma	3.24e-06	5.51e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—glaucoma	3.22e-06	5.48e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	3.22e-06	5.47e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—glaucoma	3.19e-06	5.42e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP1B1—glaucoma	3.17e-06	5.39e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCA1—glaucoma	3.17e-06	5.39e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—glaucoma	3.16e-06	5.37e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CAV1—glaucoma	3.16e-06	5.37e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CAV1—glaucoma	3.13e-06	5.32e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—glaucoma	3.13e-06	5.32e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—glaucoma	3.11e-06	5.29e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOS3—glaucoma	3.06e-06	5.21e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—glaucoma	3.03e-06	5.15e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—glaucoma	2.98e-06	5.07e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CDKN1B—glaucoma	2.97e-06	5.04e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CDKN1B—glaucoma	2.92e-06	4.96e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CDKN1B—glaucoma	2.91e-06	4.95e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—glaucoma	2.91e-06	4.95e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CDKN1B—glaucoma	2.9e-06	4.94e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—glaucoma	2.9e-06	4.93e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CDKN1B—glaucoma	2.89e-06	4.92e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—glaucoma	2.87e-06	4.88e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CDKN1B—glaucoma	2.87e-06	4.87e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	2.86e-06	4.86e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—glaucoma	2.81e-06	4.78e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—glaucoma	2.79e-06	4.75e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—glaucoma	2.75e-06	4.67e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—glaucoma	2.72e-06	4.62e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—glaucoma	2.71e-06	4.6e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—glaucoma	2.7e-06	4.6e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—glaucoma	2.7e-06	4.59e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—glaucoma	2.7e-06	4.59e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—glaucoma	2.69e-06	4.57e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—glaucoma	2.68e-06	4.56e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CAV1—glaucoma	2.68e-06	4.55e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—glaucoma	2.68e-06	4.55e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	2.65e-06	4.51e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—glaucoma	2.65e-06	4.51e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—glaucoma	2.65e-06	4.5e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—glaucoma	2.62e-06	4.45e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—glaucoma	2.6e-06	4.42e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—glaucoma	2.59e-06	4.4e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—glaucoma	2.53e-06	4.31e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTM1—glaucoma	2.53e-06	4.31e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—glaucoma	2.47e-06	4.19e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—glaucoma	2.46e-06	4.18e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—glaucoma	2.44e-06	4.14e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—glaucoma	2.43e-06	4.13e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—glaucoma	2.42e-06	4.12e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—glaucoma	2.41e-06	4.1e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—glaucoma	2.41e-06	4.09e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—glaucoma	2.39e-06	4.06e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—glaucoma	2.38e-06	4.05e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—glaucoma	2.38e-06	4.04e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—glaucoma	2.37e-06	4.04e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—glaucoma	2.37e-06	4.03e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—glaucoma	2.32e-06	3.94e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—glaucoma	2.24e-06	3.81e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—glaucoma	2.21e-06	3.75e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—glaucoma	2.2e-06	3.74e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—glaucoma	2.18e-06	3.71e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—glaucoma	2.17e-06	3.68e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—glaucoma	2.12e-06	3.61e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—glaucoma	2.11e-06	3.59e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—glaucoma	2.08e-06	3.54e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAV1—glaucoma	2.07e-06	3.51e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—glaucoma	2.05e-06	3.49e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—glaucoma	2.02e-06	3.44e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—glaucoma	2.02e-06	3.44e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—glaucoma	1.86e-06	3.17e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—glaucoma	1.85e-06	3.15e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—glaucoma	1.83e-06	3.12e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—glaucoma	1.83e-06	3.11e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—glaucoma	1.82e-06	3.1e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—glaucoma	1.82e-06	3.09e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—glaucoma	1.8e-06	3.06e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—glaucoma	1.8e-06	3.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—glaucoma	1.67e-06	2.84e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—glaucoma	1.56e-06	2.66e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—glaucoma	1.43e-06	2.43e-05	CbGpPWpGaD
